newsfilter
← Latest News
Business Wire·

2seventy bio Announces New Strategic Path Forward

- Company to focus exclusively on commercialization and development of Abecma, in partnership with Bristol Myers Squibb - - Company to sell R&D pipeline to Regeneron to launch Regeneron Cell Medicines business led